|
|
|
Insider
Information: |
Bancroft Charles A |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
168,937 |
|
Indirect Shares
|
300,000 |
|
|
Direct
Value |
$6,424,696 |
|
|
Indirect Value
|
$12,702,000 |
|
|
Total
Shares |
468,937 |
|
|
Total
Value |
$19,126,696 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bristol-Myers Squibb Co |
BMY |
EVP, Head of Integration |
2020-03-10 |
137,534 |
2020-03-10 |
300,000 |
Premium* |
|
Colgate Palmolive Co |
CL |
Director |
2018-05-14 |
5,455 |
2017-05-15 |
0 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director |
2020-04-02 |
25,948 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2012-03-04 |
4 |
D |
$32.59 |
$24,312 |
D/D |
(746) |
60,096 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2013-03-03 |
4 |
D |
$37.15 |
$28,123 |
D/D |
(757) |
72,806 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2012-03-03 |
4 |
D |
$32.59 |
$29,494 |
D/D |
(905) |
58,790 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Financial Officer |
|
2011-03-02 |
4 |
D |
$25.39 |
$54,131 |
D/D |
(2,132) |
40,783 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2016-11-01 |
4 |
D |
$50.80 |
$70,917 |
D/D |
(1,396) |
186,398 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2014-11-01 |
4 |
D |
$58.19 |
$81,291 |
D/D |
(1,397) |
98,269 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2012-03-02 |
4 |
D |
$32.59 |
$88,514 |
D/D |
(2,716) |
57,208 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2015-11-01 |
4 |
D |
$65.75 |
$91,787 |
D/D |
(1,396) |
162,561 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2018-12-02 |
4/A |
D |
$53.46 |
$145,197 |
D/D |
(2,716) |
339,806 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2018-12-02 |
4 |
D |
$53.46 |
$145,197 |
D/D |
(2,716) |
203,401 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2012-03-01 |
4 |
D |
$32.64 |
$146,978 |
D/D |
(4,503) |
52,453 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2012-03-06 |
4 |
D |
$32.33 |
$149,559 |
D/D |
(4,626) |
66,795 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2016-12-02 |
4 |
D |
$55.96 |
$161,333 |
D/D |
(2,883) |
189,918 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2017-12-02 |
4 |
D |
$62.47 |
$180,039 |
D/D |
(2,882) |
264,888 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2014-03-10 |
4 |
D |
$56.14 |
$235,563 |
D/D |
(4,196) |
164,185 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2014-03-06 |
4 |
D |
$55.56 |
$307,580 |
D/D |
(5,536) |
159,062 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2015-03-02 |
4 |
D |
$62.30 |
$400,776 |
D/D |
(6,433) |
111,330 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2015-03-06 |
4 |
D |
$65.12 |
$414,619 |
D/D |
(6,367) |
171,702 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2016-03-06 |
4 |
D |
$64.71 |
$416,409 |
D/D |
(6,435) |
170,418 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2015-03-10 |
4 |
D |
$65.53 |
$531,645 |
D/D |
(8,113) |
181,609 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2015-03-10 |
4/A |
D |
$65.53 |
$531,645 |
D/D |
(8,113) |
160,857 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2017-02-28 |
4 |
OE |
$27.01 |
$610,372 |
D/D |
22,598 |
212,516 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2018-02-23 |
4 |
OE |
$22.14 |
$829,364 |
D/D |
37,460 |
302,348 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2014-02-14 |
4 |
OE |
$22.73 |
$870,038 |
D/D |
36,251 |
130,266 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Financial Officer |
|
2019-02-28 |
4 |
OE |
$17.51 |
$925,999 |
D/D |
52,884 |
392,690 |
0 |
- |
|
117 Records found
|
|
Page 4 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|